General cellular redox systems and phase II detoxification pathways

General cellular redox systems and phase II detoxification pathways represent a coordinated network of enzymes and signaling molecules that protect cells from oxidative stress and chemical insults. Phase II detoxification primarily involves conjugation reactions, where enzymes like glutathione S-transferases (GSTs) and UDP-glucuronosyltransferases (UGTs) attach polar moieties to xenobiotics to facilitate their excretion [1]. These systems are largely regulated by the Keap1-Nrf2 signaling axis, which senses electrophilic stress and triggers the expression of antioxidant response element (ARE)-containing genes [2]. In clinical contexts, these pathways are critical for drug metabolism; for instance, the depletion of glutathione during acetaminophen metabolism can lead to hepatotoxicity [3]. While these systems are vital for preventing DNA damage and carcinogenesis, their over-activation in established tumors can lead to multi-drug resistance by neutralizing chemotherapeutic agents [4]. Consequently, pharmacological modulation of these pathways is a major area of research for both chemoprevention and overcoming therapy resistance in cancer and neurodegenerative diseases [5]. Because this entry encompasses a broad biological system rather than a single protein, it is typically categorized as a pathway or mechanism of action rather than a discrete drug target.

Other names

Phase II metabolismAntioxidant response element pathwayXenobiotic metabolismRedox homeostasis systemPhase II drug-metabolizing enzymes

Induction of cytoprotective gene expression via the Nrf2-Keap1 signaling axis and enzymatic conjugation of electrophilic metabolites to increase water solubility for excretion.